Add Yahoo as a preferred source to see more of our stories on Google. Sugar can lead to high blood sugar and contributes to the development of diabetes. Monitoring blood sugar is a crucial part of ...

Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

The U.S. Food and Drug Administration has cleared the Nova StatStrip Glucose Hospital Meter System for use with critically ill patients, making it the first blood glucose monitoring system approved ...

Blood glucose monitoring systems (BGMS) have become an integral component in the management of diabetes, providing patients and clinicians with essential real‐time information to guide treatment ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The best glucose meter can make a huge difference in your diabetes care. Whether you’re prediabetic, type ...

Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...

In recent years, diabetes management has undergone a remarkable transformation with the rise in continuous glucose monitors (CGMs). These devices present patients with an easier way to maintain ...

Global healthcare company, Abbott, announced that its continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription. Lingo contains a biosensor and mobile app that ...

TEL AVIV, Israel--(BUSINESS WIRE)--HAGAR, the developer of GWave, a revolutionary non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood, ...

Monitoring of the body’s blood sugar is essential to the treatment of diabetes. But getting effective glucose readings has long been a challenge, according to UW Medicines Diabetes Institute professor ...

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose ...